Showing 9441-9450 of 18069 results for "".
- The Dawn of Immunotherapy in Head and Neck Cancer: Pembrolizumab's Rolehttps://reachmd.com/news/the-dawn-of-immunotherapy-in-head-and-neck-cancer-pembrolizumabs-role/2475186/Despite aggressive multimodal strategies, survival gains in locally advanced head and neck squamous cell carcinoma have been marginal, with reports indicating an average annual improvement of only 0.28%, highlighting the need for new therapeu
- Modern Impacts of Lifestyle and Environmental Factors on Hypertension Riskhttps://reachmd.com/news/modern-impacts-of-lifestyle-and-environmental-factors-on-hypertension-risk/2475161/Modern environmental and lifestyle factors are reshaping our understanding of hypertension risk, revealing that non-genetic influences like per- and polyfluoroalkyl substances and seasonal behaviors can drive blood pressure elevations startin
- Hypertension Management: The Impact of FDA's Two-Front Innovationhttps://reachmd.com/news/hypertension-management-the-impact-of-fdas-two-front-innovation/2475162/Clinicians face stubborn adherence gaps and variable patient responses in hypertension, yet the FDA approval of a three-agent single-tablet combination and emerging genetic insights are poised to transform management strategies. Despit
- AI-Powered Imaging Revolutionizes Early Glaucoma Detectionhttps://reachmd.com/news/ai-powered-imaging-revolutionizes-early-glaucoma-detection/2475149/AI-Powered Imaging is revolutionizing ophthalmology by enabling detection of glaucomatous changes at a stage before clinical methods can reveal functional loss, opening a new window to prevent irreversible vision damage. Early glaucoma
- Evolving Cancer and Cardiovascular Safety in JAK Inhibitorshttps://reachmd.com/news/evolving-cancer-and-cardiovascular-safety-in-jak-inhibitors/2475152/As JAK inhibitors become integral to rheumatoid arthritis management, emerging safety data from EULAR 2025 highlight evolving cancer and cardiovascular considerations that will shape patient monitoring and treatment decisions. The
- Optimizing Timing in Intracranial Pressure Monitoring: Advancing Strategies for Neurosurgical and ICU Practiceshttps://reachmd.com/news/optimizing-timing-in-intracranial-pressure-monitoring-advancing-strategies-for-neurosurgical-and-icu-practices/2475159/Significant differences in timing between neurosurgeons and ICU physicians, as reported in the TIMING-ICP study, affect the management of intracranial hypertension.
- Gut-Brain Insights in Parkinson’s: New Avenues for Comprehensive Carehttps://reachmd.com/news/gut-brain-insights-in-parkinsons-new-avenues-for-comprehensive-care/2475169/Recent insights into gut-brain signaling expose how microbial imbalances, potentiated by environmental chemicals, accelerate non-motor symptom burden in Parkinson’s disease. Despite advances in dopaminergic therapies, neurologists rout
- Immunotherapy Combinations in Oncology: Expanding Boundarieshttps://reachmd.com/news/immunotherapy-combinations-in-oncology-expanding-boundaries/2475158/As immunotherapy is reshaping oncology, oncologists are leveraging combination therapies to push treatment boundaries and enhance patient outcomes. Combining immunotherapy with targeted therapies has been shown to
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- GALDA Co-Director Explains Organization's Work and Impacthttps://reachmd.com/news/GALDA-Co-Director-Explains-Organizations-Work-Impact/2475171/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo